Senior insider sale
President and COO at SYNDAX PHARMACEUTICALS INC — senior position signals high conviction
$882.4K
39.22K shares
What this filing means
METZGER MICHAEL A plans to sell 39.22K shares of SYNDAX PHARMACEUTICALS INC valued at approximately $882.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/8/2026ACC: 0001950047-26-006967
Officer· President and COO
Since Feb 2019
39.22K
Shares to sell
$882.4K
Approx. market value
32.38K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
7/8/2026
32.38KTotal acquired32.38K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/8/2026 | Exercise of Stock Options Cash | 32.38K | — |
| Total | 32.38K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
6.85K
Market value
$130.0K
6/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
32.38K
Market value
$752.4K
7/8/2026
Total
Units
39.22K
Value
$882.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/1/2026 | 6.85K | $130.0K | — | Completed |
| Planned — Approximate Date | ||||
7/8/2026 | 32.38K | $752.4K | NASDAQ | Planned |
| Total | 39.22K | $882.4K | ||